MedPath
FDA Approval

Naprosyn

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 16, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Naproxen(250 mg in 10 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Entreprises Importfab, Inc.

Pharmaceutical Associates, Inc.

Pharmaceutical Associates, Inc.

248586117

Pharmaceutical Associates, Inc.

Pharmaceutical Associates, Inc.

Pharmaceutical Associates, Inc.

097630693

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Naprosyn

Product Details

NDC Product Code
0121-1798
Application Number
NDA018965
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
December 16, 2020
ORANGEInactive
Code: 5EVU04N5QUClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
MAGNESIUM ALUMINUM SILICATEInactive
Code: 6M3P64V0NCClass: IACT
FUMARIC ACIDInactive
Code: 88XHZ13131Class: IACT
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
PINEAPPLEInactive
Code: 2A88ZO081OClass: IACT
NaproxenActive
Code: 57Y76R9ATQClass: ACTIBQuantity: 250 mg in 10 mL
WATERInactive
Code: 059QF0KO0RClass: IACT

Naprosyn

Product Details

NDC Product Code
0121-2697
Application Number
NDA018965
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
December 16, 2020
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACT
FUMARIC ACIDInactive
Code: 88XHZ13131Class: IACT
PINEAPPLEInactive
Code: 2A88ZO081OClass: IACT
NaproxenActive
Code: 57Y76R9ATQClass: ACTIBQuantity: 500 mg in 20 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
ORANGEInactive
Code: 5EVU04N5QUClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
MAGNESIUM ALUMINUM SILICATEInactive
Code: 6M3P64V0NCClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT

Naprosyn

Product Details

NDC Product Code
0121-0899
Application Number
NDA018965
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
December 16, 2020
SUCROSEInactive
Code: C151H8M554Class: IACT
MAGNESIUM ALUMINUM SILICATEInactive
Code: 6M3P64V0NCClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACT
FUMARIC ACIDInactive
Code: 88XHZ13131Class: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
PINEAPPLEInactive
Code: 2A88ZO081OClass: IACT
ORANGEInactive
Code: 5EVU04N5QUClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
NaproxenActive
Code: 57Y76R9ATQClass: ACTIBQuantity: 125 mg in 5 mL
© Copyright 2025. All Rights Reserved by MedPath